NASDAQ · Drug Manufacturers - Specialty & Generic

Cronos Group Inc. - Common Share (CRON) Stock

$3.35 -2.76% NASDAQ: CRON Healthcare

Valuation

MetricValue
Price$3.35
Market Cap$1.23B
P/E Ratio17.44
P/B Ratio1.14
P/S Ratio6.83
EPS (TTM)$0.00
52-Week High$3.61
52-Week Low$2.28
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE6.46%
ROA5.91%
ROCE0.05%
Gross Margin42.19%
Operating Margin-7.77%
Net Margin38.95%
Debt/Equity0.00
Current Ratio19.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$65.0M$87.0M$87.0M$118.0M$149.0M
Operating Profit$-292.0M$-111.0M$-85.0M$-77.0M$-18.0M
Net Profit$-396.0M$-169.0M$-74.0M$41.0M$-10.0M
EPS$-1.07$-0.45$-0.19$0.11$-0.03
Op Margin-452.2%-128.4%-97.2%-65.1%-12.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.4B$1.2B$1.1B$1.2B$1.2B
Total Liabilities$63.0M$72.0M$44.0M$55.0M$54.0M
Cash$887.0M$765.0M$669.0M$859.0M$792.0M
Borrowings$10.0M$4.0M$3.0M$2.0M$2.0M

Latest News

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026 GlobeNewswire · Jul 16, 2026 TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell? Zacks · Jul 2, 2026 Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada GlobeNewswire · Jun 30, 2026 CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? Zacks · Jun 24, 2026 Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders GlobeNewswire · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-154.0M$-89.0M$-43.0M$19.0M$26.0M
Investing Cash Flow$-41.0M$-7.0M$-63.0M$162.0M$-104.0M
Financing Cash Flow$-13.0M$-3.0M$-1.0M$-1.0M$-20.0M
Net Cash Flow$-191.0M$-122.0M$-95.0M$190.0M$-68.0M
Free Cash Flow$-166.0M$-94.0M$-46.0M$6.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA13.99
FCF Yield4.06%
Quick Ratio15.25
Interest Coverage—
Return 1Y31.10%
Return 3Y48.11%
Return 5Y-63.53%

Ownership

Insiders Held48.55%
Institutions Held15.64%
Institutions Float Held30.39%
Institutional HolderSharesReport Date
Chescapmanager LLC7,942,7372026-03-31
Shaw D.E. & Co., Inc.7,618,2272026-03-31
Pillsbury Lake Capital LLC4,223,0042026-03-31
Tidal Investments LLC4,026,8922026-03-31
Dimensional Fund Advisors LP2,679,0512026-03-31

About Cronos Group Inc. - Common Share

Cronos Group Inc. - Common Share is led by CEO Michael Ryan Gorenstein, employs 459 people, headquartered in CA, publicly traded since 2018.

Cronos Group Inc. - Common Share (CRON) stock trades at $3.35 with a market capitalization of $1.23B. The stock is valued at a price-to-earnings (P/E) ratio of 17.44, price-to-book of 1.14, price-to-sales of 6.83. Over the past 52 weeks the stock has ranged between $2.28 and $3.61, and currently trades 7.2% below its 52-week high.

On profitability, Cronos Group Inc. - Common Share generates a return on equity (ROE) of 6.46%, return on capital employed of 0.05%, an operating margin of -7.77%, a net profit margin of 38.95%.

Cronos Group Inc. - Common Share by the numbers, 2016–2025

Between 2016 and 2025 Cronos Group Inc. - Common Share reported revenue of $0 rising to $149.0M. Compounded, revenue has grown 26.0% a year over five years, 19.6% over three, 26.3% over the last twelve months. Net profit fell to $-10.0M.

Operating margin went from -516.8% in 2016 to -12.0% in 2025, a gain of 504.9 percentage points. The most recent net margin is 38.95%. On a trailing twelve-month basis to Jun '26, revenue is $243.0M and net profit $70.0M.

Borrowings fell from $3.0M to $2.0M, cash from operations was $26.0M in the latest year, positive in 2 of the last 10.

Return on equity has averaged -9.6% over five years, and was -0.9% in the most recent year.

The share price itself has compounded at -21.1% a year over five years, 15.4% over three, 36.0% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Cronos Group Inc. - Common Share (CRON) — frequently asked questions

What is Cronos Group Inc. - Common Share (CRON) stock price today?

Cronos Group Inc. - Common Share (CRON) is currently trading at $3.35, down 2.76% today.

What is CRON P/E ratio?

Cronos Group Inc. - Common Share's P/E ratio is 17.44. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is CRON return on equity (ROE)?

Cronos Group Inc. - Common Share's return on equity (ROE) is 6.46%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Cronos Group Inc. - Common Share's market cap?

Cronos Group Inc. - Common Share has a market capitalization of $1.23B.

Does CRON pay a dividend?

Cronos Group Inc. - Common Share is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does CRON carry?

Cronos Group Inc. - Common Share has a debt-to-equity ratio of 0.00. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is CRON's profit margin?

Cronos Group Inc. - Common Share reports a net profit margin of 38.95% — the share of revenue left after every cost, including tax and interest.

What sector is CRON in?

Cronos Group Inc. - Common Share is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is CRON listed on?

Cronos Group Inc. - Common Share trades on NASDAQ under the ticker CRON.

What is CRON's 52-week range?

Over the last year Cronos Group Inc. - Common Share has traded between $2.28 and $3.61.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens CRON currently matches

On the figures above, Cronos Group Inc. - Common Share passes the filters for 15 of our ready-made screens, among them Low Debt Stocks, High Profit Margin Stocks, Penny Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low Debt StocksHigh Profit Margin StocksPenny StocksSmall Cap StocksStocks Under $5Stocks Under $10Stocks With PE Under 20Debt Free Stocks Under $100Debt Free StocksStocks Under $100Stocks Under $50Stocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.